1. Clifton GL, Robertson CS, Grossman RG, Hodge S, Foltz R, Garza C. The metabolic response to severe head injury. J Neurosurg. 1984 Apr;60(4):687-96.
2. Rabow L, DeSalles AF, Becker DP, Yang M, Kontos HA, Ward JD, et al. CSF brain creatine kinase levels and lactic acidosis in severe head injury. J Neurosurg. 1986Nov;65(5):625-9.
3. Shapira Y, Yadid G, Cotev S, Shohami E. Accumulation of calcium in the brain following head trauma. Neurol Res. 1989 Sep;11(3):169-72.
4. Bullock R,Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery.1999;45:207-217.
5. Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF. Factors affecting excitatory amino acid release following severe human headinjury. JNeurosurg. 1998 Oct;89(4):507-18.
6. Ikeda Y, Long DM. The molecular basis ofoxygen free radicals. Neurosurgery. 1990;27:1-11.
7. Kiwak KJ, Moskowitz MA, Levine L. Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg. 1985 Jun;62(6):865-9.
8. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS.
Brain ischemia and reperfusion: molecular mechanisms ofneuronal injury.JNeurol Sci. 2000 Oct 1;179(S 1-
2):1-33.
9. De Salles AF, Muizelaar JP, Young HF. Hyperglicemia cerebrospinal fluid lactic acidosis and cerebral blood flow in in severely head injured patients. Neurosurgery. 1987;21:45-50.
10. Peters T. Calcium in physiological and pathological cell function. EurNeurol. 1986;25:27-44.
11. Trigle DJ. Calcium antagonists:history and perspective. Stroke. 1990;21:49-58.
12. Gutteridge JM, Halliwell B. The measurement and mechanism oflipid peroxidation in biological systems. Trends Biochem Sci.1990;15:129-135.
13. Kirsch JR, Helfaer MA, Lange DG, Traystman RJ. Evidence for free radical mechanisms ofbrain injury resulting from ischemia/reperfusion-induced events. J Neurotrauma. 1992;23(10):1479-85.
14. Hall ED. Free radicals and CNS injury. Crit Care Clin.1989;5(4):793-805.
15. Callaway JK, Beart PM, Jarrott B. A reliable procedure for comparison ofantioxidants in rat brain homogenates. J Pharmacol Toxicol Methods.1998;39:155-162.
16. Drapper HH, Hadley M. Malondialdehyde determination as index oflipid peroxidation. Methods inenzymology. 1990;186;421-430.
17. Halliwell B Chiroce S. Lipid peroxidation it's mechanism measurement and signifiance. Am J Clin. 1993;57:715-25.
18. Bereczki D, Mihâlka L, Szatmâri S, Fekete K, Di Cesar D, Fülesdi B, Csiba L, Fekete I. Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke. 2003 Jul;34(7):1730-5.
19. Desesso JM, Scialli AR, Goeringer GC. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity ofhydroxyurea in rabbits. Teratology. 1994 Apr;49(4):248-59.
20. Christopher SG. The treatment ofbrain injury. United StatesPatents. 1996;(5):527- 533.
21. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects ofcontusions in the rat. Brain Res. 1981 Apr27;211(1):67-77.
22. Lowry OH, Rosebrough NJ, Farr WL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-272.
23. Kitao T, Hattori K. Inhibition oferythrocyte ATPase activity by aclacynomycin and reverse effect of ascorbate on ATPase activity. Experientia. 1983;39:1362-64.
24. Tyurin VA, Tyurina YY, Borisenko GG, Sokolova TV. Ritov VB, Quinn PJ, et al. Oxidative stress following traumatic brain injury in rats: quantitation ofbiomarkers and detection of free radical intermediates. J Neurochem. 2000 Nov;75(5):2178-89.
S.D.Ü. Tıp pak.
Derg
. 2010:17(3)/7-12
12
Aköz, Mannitol
i
n head trauma
25. Hall ED, Braughler JM. Free radicals in CNS injury. Res Publ Assoc ResNervMentDis.1993;71:81-105.
26. Cauzinille L. Cranio-Cerebral Trauma: What and When to Decide. 26th WSAVA Congress Proceedings. August 8-11, 2001 Vancouver, British Columbia, Canada.
27. Betz AL, Ennis SR, Schielke GP, HoffJT. Blood-to-brain sodium transport in ischemic brain edema. Adv Neurol. 1990; 52: 73-80.
28. Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD. Effect ofmannitol on cerebral blood flow and cerebral perfusion pressure in human headinjury. JNeurosurg. 1985 Jul;63(1):43-8.
29. Maioriello AV, Chaljub G, Nauta HJ, Lacroix M. Chemical shift imaging ofmannitol in acute cerebral ischemia. Case report. J Neurosurg. 2002
Sep;97(3):687-91.
30. Bullock R. Mannitol and other diuretics in severe neurotrauma. New Horiz 1995;3(3):448-52.
31. Schierhout G, Roberts I. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2000;(2):CD001049.
32. Brain Trauma Foundation. The use ofmannitol severe headinjury. JNeurotrauma 1996;13(11):705-9.
33. Stover JF, Morganti-Kosmann MC, Lenzlinger PM, Stocker R, Kempski OS, Kossmann T. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J Neurotrauma. 1999;16:135-142.
34. Muir KW. Less KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke.1995;26:503-513.
35. Koura SS, Doppenberg EM, MarmarouA, Choi S, Young HF, Bullock R. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998;71:244-6.
36. Ustün ME, Gürbilek M, Ak A, Vatansev H, Duman A. Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med. 2001;27:264-68.
37. Katayama Y, Fukuchi T, Mc Kee A, Terashi A. Effect ofhyperglisemia on pyruvate dehyrogenase activity and energy metabolites during ischemia and reperfiision in geril brain. Brain Res. 1998;788:302-304.
38. Damas, Hans P. Management of severely head injured patients during the first 24 hours. Which spesific therapeutics? Ann Fr Anesth Reanim. 2000;19(4):326-
32.
39. Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev2001;(1):CD001153.
Thank you for copying data from http://www.arastirmax.com